-8%

est. 2Y upside i

HealthcareAI & MLSeries B

Rank

#2487

Sector

HealthTech, Medical Imaging, Artificial Intelligence

Est. Liquidity

~4Y

Data Quality

Data: Low

Vista.ai is a speculative private company with no disclosed revenue or growth data.

Last updated: July 19, 2026

Bull (20%)+68%

Vista.ai achieves rapid adoption and IPO, expanding to multiple anatomies. Revenue grows to $8.4M and maintains premium multiple of 10x, implying $84M exit. Upside 68% from estimated $100M entry.

Base (55%)-66%

Vista.ai grows steadily but compresses to public comp multiples of 4x revenue, implying $33.6M exit. Upside -66.4%.

Bear (25%)-100%

Competition from incumbents and slow adoption lead to multiple compression to 1.5x and exit below preference stack of $42.1M, common stock wiped out. Upside -100%.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

4210%

Total funding of $42.1M represents 42% of estimated $100M valuation, meaning preferred shareholders have a large claim on exit proceeds.

Dilution Risk

low

Recent Series B in Jan 2026 likely provides 2+ years runway with 30 employees and low capital intensity, reducing near-term dilution risk.

Secondary Liquidity

none

No secondary market activity reported; employee equity is illiquid until an exit event.

Questions to Ask at the Interview

Strategic questions based on Vista's data — designed to show you've done your homework.

  • 1

    “What is the current ARR and its growth trajectory over the last 12 months?”

  • 2

    “How does Vista.ai's technology differentiate from incumbent AI initiatives at Siemens and GE?”

  • 3

    “What is the expected timeline to profitability or a liquidity event, and what milestones drive that?”

Community

Valuation Sentiment

Our model estimates -8% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.